Journal of Experimental & Clinical Cancer Research (Jan 2022)

MiR-423-5p prevents MALAT1-mediated proliferation and metastasis in prostate cancer

  • Carmela Ferri,
  • Anna Di Biase,
  • Marco Bocchetti,
  • Silvia Zappavigna,
  • Sarah Wagner,
  • Pauline Le Vu,
  • Amalia Luce,
  • Alessia Maria Cossu,
  • Jayakumar Vadakekolathu,
  • Amanda Miles,
  • David J. Boocock,
  • Alex Robinson,
  • Melanie Schwerdtfeger,
  • Virginia Tirino,
  • Federica Papaccio,
  • Michele Caraglia,
  • Tarik Regad,
  • Vincenzo Desiderio

DOI
https://doi.org/10.1186/s13046-021-02233-w
Journal volume & issue
Vol. 41, no. 1
pp. 1 – 16

Abstract

Read online

Abstract Background The long non-coding RNA (lncRNA), MALAT1, plays a key role in the development of different cancers, and its expression is associated with worse prognosis in patients. However, its mechanism of action and its regulation are not well known in prostate cancer (PCa). A general mechanism of action of lncRNAs is their interaction with other epigenetic regulators including microRNAs (miRNAs). Methods Using lentiviral stable miRNA transfection together with cell biology functional assays and gene expression/target analysis, we investigated the interaction between MALAT1 and miR-423-5p, defined as a target with in silico prediction analysis, in PCa. Results Through bioinformatic analysis of data available from TCGA, we have found that MALAT1 expression correlates with high Gleason grade, metastasis occurrence, and reduced survival in PCa patients. These findings were validated on a TMA of PCa showing a significant correlation between MALAT1 expression with both stage and grading. We report that, in PCa cells, MALAT1 expression and activity is regulated by miR-423-5p that binds MALAT1, downregulates its expression and inhibits its activity in promoting proliferation, migration, and invasion. Using NanoString analysis, we unraveled downstream cell pathways that were affected by miR-423-5p expression and MALAT1 downregulation and identified several alterations in genes that are involved in metastatic response and angiogenic pathways. In addition, we showed that the overexpression of miR-423-5p increases survival and decreases metastases formation in a xenograft mouse model. Conclusions We provide evidence on the role of MALAT1 in PCa tumorigenesis and progression. Also, we identify a direct interaction between miR-423-5p and MALAT1, which results in the suppression of MALAT1 action in PCa.

Keywords